INTRODUCTION: The aim of this article was to describe the study design, participants and baseline characteristics of The Danish General Suburban Population Study (GESUS) and to compare suburban participants with age- and gender-matched urban participants from the Copenhagen General Population Study (CGPS). MATERIAL AND METHODS: Data from questionnaire, health examination, biochemical measurements and public registers were collected. RESULTS: In GESUS the overall participation rate was 49.3% (response n = 10,621 of total n = 21,557). Among people aged 40-79 years, the participation rate was 53.9% (8,797/16,310). Participants were more frequently women, had a higher median age, a higher frequency of marriage/registered partnerships, but had a lower frequency of co-morbidities and death in the follow-up period (January 2010-May 2011 (diseases)/June 2011 (death) than the non-participants. GESUS has sufficient power to study effects of rare and common exposures or genetic variants on the occurrence of common multifactorial diseases. Compared with an age- and gender-matched urban population (n = 10,618, CGPS), participants in GESUS (n = 10,618) were less physically active, smoked less and ingested less alcohol, had higher anthropometric measures, less undiagnosed hypertension but more undiagnosed diabetes, had a lower frequency of elevated total cholesterol and low-density lipoprotein chol-esterol but higher frequency of decreased high-density lipoprotein cholesterol and elevated triglycerides. CONCLUSION: In GESUS, participants had a better health profile than non-participants, and participants in GESUS had a different cardiovascular risk profile than participants in the CGPS. FUNDING: The study received funding from the following: Johan and Lise Boserup Foundation; TrygFonden; Det Kommunale Momsfond; Johannes Fog's Foundation; Region Zealand; Region Zealand Foundation; Naestved Hospital; Naestved Hospital Foundation; The National Board of Health; Danish Agency for Science, Technology and Innovation. TRIAL REGISTRATION: not relevant.
INTRODUCTION: The aim of this article was to describe the study design, participants and baseline characteristics of The Danish General Suburban Population Study (GESUS) and to compare suburban participants with age- and gender-matched urban participants from the Copenhagen General Population Study (CGPS). MATERIAL AND METHODS: Data from questionnaire, health examination, biochemical measurements and public registers were collected. RESULTS: In GESUS the overall participation rate was 49.3% (response n = 10,621 of total n = 21,557). Among people aged 40-79 years, the participation rate was 53.9% (8,797/16,310). Participants were more frequently women, had a higher median age, a higher frequency of marriage/registered partnerships, but had a lower frequency of co-morbidities and death in the follow-up period (January 2010-May 2011 (diseases)/June 2011 (death) than the non-participants. GESUS has sufficient power to study effects of rare and common exposures or genetic variants on the occurrence of common multifactorial diseases. Compared with an age- and gender-matched urban population (n = 10,618, CGPS), participants in GESUS (n = 10,618) were less physically active, smoked less and ingested less alcohol, had higher anthropometric measures, less undiagnosed hypertension but more undiagnosed diabetes, had a lower frequency of elevated total cholesterol and low-density lipoprotein chol-esterol but higher frequency of decreased high-density lipoprotein cholesterol and elevated triglycerides. CONCLUSION: In GESUS, participants had a better health profile than non-participants, and participants in GESUS had a different cardiovascular risk profile than participants in the CGPS. FUNDING: The study received funding from the following: Johan and Lise Boserup Foundation; TrygFonden; Det Kommunale Momsfond; Johannes Fog's Foundation; Region Zealand; Region Zealand Foundation; Naestved Hospital; Naestved Hospital Foundation; The National Board of Health; Danish Agency for Science, Technology and Innovation. TRIAL REGISTRATION: not relevant.
Authors: Anders Jorgensen; Kristin Köhler-Forsberg; Trine Henriksen; Allan Weimann; Ivan Brandslund; Christina Ellervik; Henrik E Poulsen; Gitte Moos Knudsen; Vibe G Frokjaer; Martin B Jorgensen Journal: Transl Psychiatry Date: 2022-05-16 Impact factor: 7.989
Authors: Anne-Dorthe Feldthusen; Palle L Pedersen; Jacob Larsen; Tina Toft Kristensen; Christina Ellervik; Jan Kvetny Journal: J Pregnancy Date: 2015-08-17
Authors: Tina Toft Kristensen; Jacob Larsen; Palle Lyngsie Pedersen; Anne-Dorthe Feldthusen; Christina Ellervik; Søren Jelstrup; Jan Kvetny Journal: J Thyroid Res Date: 2014-05-14
Authors: Andreas Heltberg; John Sahl Andersen; Jakob Kragstrup; Volkert Siersma; Håkon Sandholdt; Christina Ellervik Journal: Scand J Prim Health Care Date: 2017-03-03 Impact factor: 2.581
Authors: Christian R Juhl; Helle K M Bergholdt; Iben M Miller; Gregor B E Jemec; Jørgen K Kanters; Christina Ellervik Journal: Nutrients Date: 2018-08-08 Impact factor: 5.717
Authors: Andreas Heltberg; Volkert Siersma; John Sahl Andersen; Christina Ellervik; Henrik Brønnum-Hansen; Jakob Kragstrup; Niels de Fine Olivarius Journal: BMC Endocr Disord Date: 2017-12-08 Impact factor: 2.763